Fig. 3From: Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapyCumulative incidence of symptomatic cardiac adverse events by a heart V5, b heart V10, and c heart V20. d Overall survival by symptomatic cardiac adverse eventsBack to article page